Your browser doesn't support javascript.
loading
The effect of Fingolimod on patients with moderate to severe COVID-19.
Teymouri, Soheil; Pourbayram Kaleybar, Siamak; Hejazian, Seyyed Sina; Hejazian, Seyyedeh Mina; Ansarin, Khalil; Ardalan, Mohammadreza; Zununi Vahed, Sepideh.
Afiliación
  • Teymouri S; Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Pourbayram Kaleybar S; Kidney Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hejazian SS; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hejazian SM; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ansarin K; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ardalan M; Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Zununi Vahed S; Kidney Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Pharmacol Res Perspect ; 11(1): e01039, 2023 02.
Article en En | MEDLINE | ID: mdl-36567519
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacol Res Perspect Año: 2023 Tipo del documento: Article País de afiliación: Irán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacol Res Perspect Año: 2023 Tipo del documento: Article País de afiliación: Irán